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Abstract—This article discusses the fundamental architectures
for optical wireless systems for biomedical applications. After
summarizing the main applications and reporting their require-
ments, we describe the characteristics of the transdermal and in-
body optical channels as well as the challenges that they impose in
the design of communication systems. In more detail, we provide
three possible architectures for transdemal communications,
namely electro-optical (EO) monitoring, opto-electrical (OE) and
all-optical (AO) for neural stimulation, which are currently under
investigation, whereas for in-body communications, we provide a
nano-scale AO (NAO) concept. For each architecture, we discuss
the main operation principles, the technology enablers and
research directions for their development. Finally, we highlight
the necessity of designing an information theoretic framework
for the analysis and design of the physical (PHY) and medium
access control (MAC) layers, which takes into account the
channels’ characteristics.
I. INTRODUCTION
Medical implants (MIs) and nano-scale wireless networks
(NWNs) have been advocated as an effective-solution to
numerous health-issues. Typical MIs consist of an out-of-body
(in-body) unit that captures the stimulus (bio-signal), converts
it into a radio-frequency (RF) signal and wirelessly transmits
it into the in-body (out-of-body) unit, which stimulates (mon-
itors) the corresponding nerve (bio-process). The main disad-
vantage of this approach is its incapability to support high-
data-rates required for neural-prosthesis applications, under
reasonable transmission-power. Additionally, there is a lack
of effectiveness and flexibility in co-existing with the huge
amount of RF-devices that are expected to conquer the beyond
5G wireless world. Finally, the use of RF-frequencies prohibit
the utilization of nano-scale biomedical devices.
In view of the advances in optoelectronics and optogenetics,
very recent innovative designs have been reported, which,
by employing optical wireless communications (OWCs), are
able to deliver more compact, reliable, and energy-efficient
solutions, while, at the same time, reduce the RF-radiation
concerns [1]. The main advantages provided by OWCs are
the abundant available bandwidth, no interference from other
devices, higher achievable data rates and increased safety
for the human body. As a result, OWCs are expected to be
used for both transdermal and in-body links establishment;
hence, they will influence the fundamental technology trends
in biomedical applications for the next 10 year and beyond.
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Due to the transdermal and in-body optical channel particu-
larities, the compactness and energy limitations as well as the
directionality of the OWC links, the design and development
of OWC-based biomedical applications will have to leverage
breakthrough technological concepts. Indicative examples are
the co-design of communication and stimulation units, the
presentation of digital signal processing (DSP) schemes for
the end-to-end link from the device (biological unit) to the
biological unit (device), and the utilization of new EO, OE,
AO, and NAO interfaces. Likewise, new channel and noise
models that takes into account the peculiarities of the trans-
demal and in-body optical medium need to be developed.
Building upon which, a novel information theoretic framework
is required for the design of energy-efficient PHY and MAC
schemes, as well as the development of simultaneous wireless
information and power transfer (SWIPT) policies and resource
allocation strategies [2].
Motivated by the above, the aim of this article is to present
the vision and approach of delivering safe and high quality-
of-experience (QoE) in MIs and NWNs, identify the critical
technology gaps, and the appropriate enables. In more detail,
after presenting the biomedical applications, which can be
OWC-enabled, together with their critical design requirements,
we introduce three possible architectures for transdemal com-
munications, which are currently under investigation, whereas
for in-body communications, we discuss the NAO concept.
These architectures are expected to drastically increase the
achievable data-rate and significantly reduce the in-body de-
vices energy-consumption. For each architecture, we report
the main operation principles, technology enablers as well as
critical technology gaps. Moreover, we emphasize the need
of developing novel channel models that take into account
the transdermal and in-body optical medium particularities
as well as deriving a corresponding theoretical framework
for the performance assessment and design of the PHY and
MAC schemes.
II. BEYOND CLASSICAL BIOMEDICAL APPLICATIONS
Optical wireless MIs (OWMIs) and NWNs are envisioned
to enable a vast variety of novel biomedical applications,
such as smart drug delivery and tissue recovery, as well as
to improve the QoE and safety of the conventional ones,
not only by targeting 10 − 100 times higher-data-rates, but
also by combining them with reliability and compact designs.
Vital signals, pathogens and allergens real-time continuous
monitoring, detection of tissues and molecules abnormalities,
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Fig. 1: Biomedical applications that can be supported
by OWCs.
as well as smart drug delivery are only some examples of
several highly challenging use cases. In order to support such
application scenarios, the research world turns to the adap-
tation of THz technologies, which, by leveraging graphene
designs, is expected to utilize nano-scale transceivers. How-
ever, the safety of THz links is still questionable and these
technology are yet immature. To break these barrier, we need
to direct research towards the mature OWC concepts, identify
and categorize the possible applications and design suitable
architectures and systems [3]. In this direction, we present
the main application categories based on the link nature and
scenarios as well as their critical design parameters. These
applications are depicted in Fig. 1.
Biomedical applications requiring the establishment of
transdemal links: The main representatives of this category are
the cochlear, retinal, cortical, foot drop, implants, the gastric
stimulators, the wireless capsule endoscope, the insulin pumps,
as well as the implantable orthopedic devices. Maybe the
most successful application of such devices is cochlear im-
plants (CIs), which have restored partial hearing to more than
350, 000 people worldwide, half of whom are pediatric users,
who ultimately develop nearly normal language capability.
Conventional CIs exploit near-field magnetic communication
technologies and typically operate in low-RF frequencies, from
5 to 49 MHz, while their transmit power is in the order
of tens of mW. As a result, they cannot support high-data-
rates (in the orders of Mb/s), which are required in order
to achieve similar performance to that of cochlea, under
reasonable transmit power constraint. Transdermal-optical-link
(TOL) is an important building-block to guarantee high-speed-
connectivity between the external and internal units with low-
energy-consumption [4]. In this scenario, apart from the high
targeted data-rates ( 10 Mb/s), the critical parameters are the
latency, which should be in the order of 0.1 ms, uninterrupted
connectivity (i.e., an outage probability that is lower than
10−5), and low error rate (BER ≤ 10−4). Additionally, these
devices should support SWIPT in order to guarantee the
internal device energy autonomy.
After the successful clinical validation of CIs, neural pros-
theses were exploited in the treatment of visual impairments,
by developing retinal implants (RIs). In this application, the
implanted device is an epiretinal prosthesis that includes a
receiver antenna, a DSP unit, and an electrode array attached
in to the retina surface. The external unit consists of a
miniature-video-camera attached in glasses and a transmitter
coil, connected via a small video-processing-unit, which con-
verts the captured-video to electrical-pulse. These pulses are
transmitted wirelessly to the implanted device. Unfortunately,
the visual acuity of this approach is quite low, due to the
limitations of the stimulation unit and the achievable data-rate
of the RF-communication-link. To break through this barrier,
two solution has been reported, namely, the use of optical
stimulation approaches in order to reduce the pixel dimensions
and OWCs to increase the date-rate [1]. The critical parameters
for this application are the pixel population, which should be
higher than 60 × 60 pixels, the data-rate (∼ 100 Mb/s), and
the latency, which should be less than some decades of ms.
Gastric stimulators are used in the treatment of gastric
dysmotility disorders and obesity. They consists of two units,
namely out-of-body and in-body. The former’s main respon-
sibility is to wirelessly transfer power to the latter, which
consists of a received RF-antenna, a charge pump and a
peripheral interface controller that generates the electrical-
pulse and is connected to the electrodes. The transmission
medium is body tissue of 1 to 5 cm thickness. This is
translated to an about 4 dB penetration-loss, when RF-signals
are employed. However, if optical signals are employed, this
loss is further constrained. Except from the transmission range,
another critical parameter for this application is the in-body
unit compactness.
Biomedical implants are also used for bio-signals and bio-
processes monitoring, such as neural/brain implants, insulin
pumps and wireless capsule endoscopes. Neural/brain im-
plants, pacemakers, and insulin pumps, expect of the high-
data-rates, demand high-energy-autonomy and compactness of
the in-body unit. In other words, efficient-power-transfer that
take into account the space constraints need to be utilized.
On the other hand, wireless capsule endoscope is an ad-
hoc setup. As a result, its battery can cover the energy
demands. The main challenge of this application is to sustain
continuous-connectivity of the in-body and out-of-body units
independently of the in-body unit orientation.
In-body biomedical applications: Nanotechnology provides
a new set of tools to control matter at the atomic and molecular
scales, thus, enabling the development of nano-scale biomedi-
cal applications for nano-sensing and actuation. Nano-devices
utilized in such systems require the use of bio-compatible ma-
terials as well as communication techniques with limited elec-
tromagnetic radiation on the biological tissues [5]. Moreover,
several breakthroughs in the field of nano-photonic devices
enabled nano-scale PWCs. These applications include, among
other, diagnostic and therapeutic techniques utilizing nano-
devices, healthcare monitoring solutions that combine in-body
nano-photonic bio-sensors and non-intrusive brain-machine
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Fig. 2: Candidate architectures for transdermal optical appli-
cations.
interfaces. Among others, nano-LEDs can be leveraged as
energy-efficient compact signal sources for optical wireless
links, which meet both size and power requirements of nano-
devices [6]. Similarly, sensitive nano-PD were developed and
can be combined with nano-LEDs to form nano-sensors, which
can be utilized in compact nano-transceivers to forge fast,
short-distance wireless communication links. The aforemen-
tioned nano-transceivers when paired with nano-antennas, can
serve as nano-gateways to bridge the communication with out-
of-body devices.
Despite the achieved progress in the last years, numer-
ous challenges exist that have to be addressed in order to
achieve the desired performance of different applications.
For example, in the case of wireless network on a chip,
the main concern is to increase the capacity and data rate
of the network, while dealing with a more predictable and
controllable system model. Therefore, new challenges in terms
of nano-photonic devices and communication protocols, such
as energy-efficiency, link-capacity and reliability, have to be
addressed before NAO networks can be established as a
realistic solution.
III. CANDIDATE ARCHITECTURES
For transdermal optical links: As illustrated in Fig. 2,
three candidate architectures for transdermal OWCs have been
identified, namely OE, EO, and AO. OE and AO are suitable
for translating external stimuli, such as audio and video, into
nerve stimulation signals. Their main difference is that the
internal device of the OE unit performs DSP in the received
signal. Thus, a energy-autonomy demand for the internal
device arises. To satisfy this, a simultaneous light information
and power transfer (SLIPT) policy is utilized. In particular, the
DC part of the received signal is used for energy-harvesting,
while the AC part conveys the neural stimulation message. A
simple AC and DC separator (ADS) is employed at the internal
device consisting of a capacitor that blocks the DC component
of the received signal and forwards it to the energy harvesting
branch. At the same time, the AC component of the signal
at the output of the ADS is inserted to the DSP-unit, which
together with the STM translates the received message into
the appropriate neural-stimulation-signal.
On the other hand, in the AO, no-SLIPT is required, since
the stimulation signal is directly emitted by the out-of-body-
device. In this architecture, the in-body-device consists of a
fiber-coupling-unit, which is usually a MEM and is responsible
for the capturing of the transmitted-signal and forwarding it
to the optical-stimulator. This concept may be utilized by
employing commercially available optics and optogenetics
modules. In this scenario, DSP for mitigating the impact of
both the TOL impairments and stimulation signal is required.
The main challenge of AO is modeling the link from the
external-unit to the corresponding nerve. Another challenge
is the mapping of the transmission signal into the stimulation
one.
The EO architecture can be used for monitoring and sens-
ing bio-signals; hence, it can be employed in neural/brain
implants and insulin pumps. The in-body-device consists of
a sensing/monitoring-unit, a DSP-unit and a light-source that
emits the modulated sensed message. To cover the energy-
requirements of the in-body-device an energy-harvesting-
branch is utilized. The out-of-body-device consists of a pho-
todetector that captures the light-signal and forwards it in a
DSP-unit, responsible for message detection. The detected-
signal is forwarded to the imaging-device. Moreover, the out-
of-body-unit has a DC signal-generator with a dimming con-
troller that feeds a light-source, responsible for energy-transfer.
The major challenge of EO is to present suitable dimming
control strategies that guarantee the energy-autonomy of the
in-body-device. Moreover, this concept allows the integration
of the internal device front-end into a single-module with
superior compactness and energy-efficiency.
For nano-scale systems: For the utilization of NAO net-
works, the two architectures depicted in Fig. 3 have been iden-
tified. A common nano-node structure is considered in both
cases. Among others, each nano-node is equipped with a nano-
LED and a nano-PD that enable communication with other
nano-nodes, as well as an energy-harvester that replenishes
the energy stored in a nano-capacitor. This enables circulating
nano-nodes to overcome the energy-limitations and even have
practically infinite lifetime. Depending on the application, the
nano-nodes can be equipped with nano-sensors and/or nano-
actuators for the monitoring and/or manipulation of biological
processes, respectively.
Initially, the architecture presented in Fig. 3(a) incorporates
an intermediate nano-device, called nano-gateway. This device
is responsible for forwarding the data collected from the nano-
nodes to the external interface. The link between the latter
and the nano-gateway can be established on the optical or the
RF spectrum, depending on the application characteristics. For
example, in close range communications the optical link has
been proven to outperform the corresponding RF, while for
longer range applications the required optical beam intensity
for achieving adequate signal quality can be destructive to the
human tissue due to extensive increase in temperature.
In the scenario depicted in Fig. 3(b), the architecture
consists of the nano-nodes and the nano-router. The former
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Fig. 3: Candidate architectures for in-body optical applica-
tions.
move throughout the body with a pattern that varies with the
application, while the latter collects the gathered information
when the nano-nodes are in range [7]. For example, if we
consider a scenario where the nano-nodes are injected into the
bloodstream and the nano-router is placed on the outer surface
of the skin, as the nano-node travel through the circulatory
system, they communicate with the nano-router when they are
positioned close enough to it.
The main differentiating factor between the two candidate
architectures is scalability. Specifically, the aforementioned
structure of the nano-network is capable of being multiplied
throughout the human-body, in both deep-tissue and near the
surface alike. By placing the nano-gateways with appropriate
distance between them, the architecture shown in Fig. 3(a) can
be repeated multiple times. However, both architectures share
the same concerns such as limited energy consumption, limited
computational capabilities, stochastic network topology.
IV. DESIGN PRINCIPLES AND TECHNOLOGY ENABLERS
The utilization of transdermal and in-body OWC systems
exploits the joint-design of information, power-transfer and
nerve-stimulation signals that can countermeasure the pecu-
liarities of the optical-channels. Aspired by this, this section
is devoted on identifying the channel characteristics and the
enabling technologies for the implementation of the candi-
date architectures.
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A. Optical wireless channel
In-body and transdermal optical-wireless channel models
are considered to be the main building-blocks for developing
the aforementioned architectures. In comparison with the out-
of-body models, these ones are required to accommodate a
number of different characteristics and biological particulari-
ties. For instance, in TOLs, the dermis content in hemoglobin
can significantly influence its light absorption in the blue
and green-yellow regions. On the other hand, the dominant
absorber in the ultraviolet and infrared regions is the epider-
mis melanin. Finally, chromophores, like bilirubin, carotene,
lipids, cell nuclei, filamentous proteins, etc. can cause further
absorption in different wavelengths. Of note, in spite of the
abundance in all tissues, due to the short communication
distance, water is not a significant light absorber in these
systems. Of note, this is one of the differences between the
transdermal/in-body and out-of-body optical channels.
The impact of the optical wireless channel particularities
with regard to path-loss is presented in Fig. 4. This figure
summarizes the main contributing elements of any tissue
which is applicable to the communication paradigms under
investigation. Moreover, the path-loss that occurs when light
of a specific wavelength travels through a tissue is a function of
the absorption coefficient of the tissue, which can be calculated
based on the tissues concentrations and absorption coefficients
of water, blood, fat and melanin [8]. From Fig. 4, we observe
that the attenuation due to the existence of blood plays a
detrimental role in the performance of the communication link.
If we consider only the blood, it is evident that a transmission
window exists after 600 nm. On the contrary, water attenuates
more intensively optical signals with higher wavelength, while
the rest of the elements have a more consistent impact. As
a result, the appropriate transmission wavelength for each
use case has to be selected based on the composition of the
intermediate tissue.
Apart from path-loss, transdermal and in-body optical links
experience wavelength-dependent particulate scattering. In
5particular, within the skin, the main source of scatter is
filamentous proteins (like keratin in epidermis and collagen
in dermis). Note than since these particles are comparable
or larger than the transmission wavelength, scattering can
be approximated as a Mie solution to Maxwell’s equations.
On the other hand, in in-body applications, tissues, such
as membranes, striations in collagen fibrils, macromolecules,
lysosomes, vesicles, mytochondria, and nuclei, are the main
scatters. Notice that membranes are usually lower than 1/10 of
the wavelength, while all the other structures are comparable
to the wavelength. Thus, scattering in tissues can be modeled
as a mixture of Rayleigh and Mie processes.
Inhomogeneities in the body content in light absorbing and
scattering structures leads to a variation of the reflective index
along the transmission path, which cause random fluctuations
in both the amplitude and phase of the received signal, i.e.
channel fading. In order to provide the theoretical framework
for the performance assessment and design of optical biomed-
ical implants, it is of high importance to deliver a stochastic
model for the accommodation of this type of fading. In this
direction, stochastic geometry approaches have been employed
(see [9] and references therein). Finally, another source of
received power uncertainty, which arises from the directional
nature of the optical links, is transceiver misalignment. As
reported in [4], this type of uncertainty can be modeled
through a stochastic process and can significantly affect the
system performance.
Another differentiation of in-body/transdermal optical com-
munications in comparison to other out-of-body applications is
the existence of neural noise. Specifically, optical approaches
for tracking neural dynamics have modeled the physical
bounds on the detection of neural spikes as photon counting
statistics (shot noise). Besides the neural noise, other noise
sources come from the receiver, like thermal, background
and dark current noises, and can be modeled as zero-mean
Gaussian processes. Their power depends on the communi-
cation bandwidth, the detector’s responsivity, the background
optical power and the intensity of the dark current, which is
generated by the photodetector in the absence of background
light. Depending on the architecture, different types of noise
determines the fundamental bounds. For example, in AO,
neural noise is expected to play the most detrimental role,
while, in OE and EO, its intensity tends to zero.
The above observations motivates the development of
generalized deterministic path-loss and statistical in-body-
particulate models for TOLs and in-body optical links that
will aid to the appropriate transmission waveform design, the
development of the PHY and MAC, as well as the utilization
of the candidate architectures. These models should take into
account the patients particularities, such as the skin color, the
composition in different structures (collagen, melanin, etc.),
the transmission wavelength, and the intensity of misalign-
ment.
B. Electrical and optical neural stimulation
Based on the stimulation type, implants can be classified
into electrical and optical. Electrical stimulation methods use
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an external electrical current to manipulate the membrane
potential directly and have been extensively used for igniting
action potentials in various types of human cells. Numerous
medical implants, such as cochlear implants, pacemakers,
and more, take advantage of these techniques. However, the
performance of electrical cell stimulation is hindered by poor
spectral coding and bandwidth scarcity of the RF spectrum.
These limitations motivated the research community to turn its
attention to the optical spectrum, which is capable of providing
large amounts of unexploited bandwidth and higher safety
for the human body [10]. As a result, optical stimulation
has been greatly investigated over the past decade, due to
the various advantages it offers over the established electrical
one. Optogenetic techniques are based on the development
of several genetically modified proteins, called opsins, which
when illuminated generate a flow of ions through the cellular
membrane that alters the membrane potential [11]. This imple-
mentation has been experimentally proven to control the cell
dynamics with higher accuracy, frequency and greater spatial
resolution.
Regarding their performance comparison, as
indicated in Fig. 5, under the same power consumption
and stimulation frequency, optical stimulation is proven to
outperform the equivalent electrical one in terms of accuracy
and power consumption, respectively. It should be noted that
the vertical doted line, which corresponds to the 15 Hz, marks
the upper frequency limit for the electrical stimulation. It is
evident that the optical stimulation is capable of generating
accurate action potentials with higher frequency while
maintaining the similar power consumption. This observation
is in agreement with several publications, which state that
optogenetics offer more precise control over the excited
neurons due to both the higher achievable frequency and
the temporal accuracy provided by the variety of existing
photosensitive opsins. In addition, the optical cell stimulation
outperforms the corresponding electrical in terms of the
stimulation success rate. This is expected due to the fact that
6the optical spectrum offers more bandwidth. However, if we
consider the fact that optical signals attenuate faster as they
travel through the human body thus offering lower geometric
spread, or in other words, higher spatial resolution, we can
deduct that optical stimulation is an overall more robust
solution for cell stimulation.
C. Energy transfer and SLIPT
A critical system design parameters in several inbody
biomedical devices is their lifetime, which depends on the
amount of available power. Replacing or removing and
recharging the battery of such device is impractical or even
impossible. To counterbalance this, energy harvesting from the
body using thermoelectric, piezoelectric, and electromagnetic
generators attracted the eye of biomedical engineers [12].
However, these approaches have two inherent disadvantages:
(i) low-harvesting-efficiency (∼ 20%); and (ii) require the
installation of extra modules that increase the implementation
cost and size. As a consequence, SLIPT policies seem to be
more appealing for biomedical applications.
In biomedical devices with SLIPT capabilities, the PD,
which is a common-choice, due to the high-data-rate that
supports, needs to be replaced with solar cells, which provide
apparent advantages in terms of harvesting-efficiency [13],
[14]. Solar cells dimensions can be different, depending on the
application for which they are used, from some nano-meters
to decades-of-centimeters. They are basically photoelectric
converters with zero bias and can be used to support both
energy-harvesting and information-decoding. From the SLIPT
utilization point of view, two fundamental policies can be
used, namely time and signal splitting. In the former, the
transmission period is divided into an energy-harvesting and
information-transfer one, while, in the latter, the DC and AC
part of the received photo-current are respectively used for
energy-harvesting and information-decoding.
Although SLIPT approaches and policies have been exten-
sively investigated in different types of OWC systems, they
cannot be straightforwardly be applied in biomedical systems,
because of the particularities of the receiver. In particular,
receivers designed for out-of-body OWC applications and have
SLIPT capabilities are equipped with solar panels. On the
other hand, in biomedical applications, they are equipped with
solar cells. As a consequence, further investigation on the
suitability of each policy in each one of the aforementioned
applications need to be conducted.
D. PHY & MAC layer
By exploiting the capabilities of the optical transceivers,
we report the new challenges and opportunities at the PHY
and MAC, including energy efficient modulation and coding
(MC), energy transfer and SWIPT policies. Consistently with
the demands of ultra-low power consumption, compact-size,
reliability and ultra-low complexity, new MC schemes that
takes into account the different type of noise and channel
particularities need to be developed. Intensity modulation and
direct detection with power adaptation may be a good ap-
proach to deal with stochastic behavior of the channel, whereas
transmission and/or reception diversity through the exploita-
tion of multiple light sources and photo-detectors can be
employed to address the pointing errors. Moreover, the chan-
nel particularities and the transceiver limitations require the
development of novel channel codes for in-body/transdermal
OWCs. The conventional capacity-approaching channel codes
are designed to maximize the data-rate for a given transmit
power. However, they demand additional transmission power,
which, in low-transmission-range communications is usually
comparable to, or even larger than, the transmit power. Another
limitation that needs to be taken into consideration is the
decoding time, which needs to be constrained according to
the application requirements. To break these barriers, we need
to characterize the error sources, i.e. both the noise nature
and the channel stochastic behavior, and examine the trade-
off between transmission power and decoding time in order
to design channel codes that minimize the aggregates transmit
and decoding power. A possible approach is the use of low-
weight coding schemes that prevent channel errors. In this
direction, efficient algorithms to determine the optimal coding-
weight and generate low-weight codes need to be investigated.
From the MAC point of view, the directional nature of
OWCs combined with the high-bit-rates increase the spatial-
synchronization requirements in nano-scale optical networks
and call for novel MAC protocols that would be able to guar-
antee transceivers alignment, device fast-tracking and routing.
In this direction, a RX-initiated schemes that allow the devices
to periodically operate in sleeping, receiving and transmitting
mode may be the solution. During the reception phase, each
device locates its neighbors and announces its availability.
When a device identifies that the intended RX or a candidate
relay is available, it switches to transmitting mode. Another
functionality that needs to be utilized is fast steering. Optical
tracking and steering is a challenge, especially when the
requirement is for low-cost, fast, lightweight control systems.
Further research will need to address the development of
appropriate field-of-view restrictions and effective beam steer-
ing and adaptive control systems for nano-scale biomedical
applications. Finally, by exploring the opportunities of multi-
hop communications, we can drastically reduce the energy
consumption. To achieve this, new routing protocols need to
be utilized that take into account the energy availability of
each nano-node as well as the application delay constraint.
V. CONCLUSIONS
In this article, we presented the concept of optical in-body
and transdermal optical communications. In more detail, after
presenting the possible biomedical applications and identifying
their requirements, we described candidate system architec-
tures and features. Due to the fact that their designs are in early
stage, it is difficult to determine their final form. However,
their enablers and technology modules were reported, namely
channel modeling, the development of novel PHY, MAC and
energy transfer schemes, and the design of appropriate stimula-
tion units. Finally, future research directions were highlighted.
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